Tricuspid atresia overview: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:


==Differentiating [[tricuspid atresia]] from Other Diseases==
==Differentiating [[tricuspid atresia]] from Other Diseases==
Patients with [[tricuspid atresia]] should be differentiated from other [[cardiac]] causes of [[cyanosis]] and [[lung]] olygemia include: [[Tetralogy of Fallot]], [[Truncus arteriosus]], [[Total anomalous pulmonary venous connection]], [[Pulmonary atresia]],  [[Tricuspid stenosis]].
Patients with [[tricuspid atresia]] should be differentiated from other [[cardiac]] causes of [[cyanosis]] and [[lung]] olygemia include: [[Tetralogy of Fallot]], [[Total anomalous pulmonary venous connection]], [[Pulmonary atresia]],  [[Tricuspid stenosis]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 15:51, 8 November 2020

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia overview

CDC on Tricuspid atresia overview

Tricuspid atresia overview in the news

Blogs on Tricuspid atresia overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief: Sara Zand, M.D.[2]Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]

Overview

Tricuspid atresia is the fourth most common cyanotic congenital heart disease after tetralogy of Fallot, transposition of the great arteries (TGA), and hypoplastic left heart syndrome, whether the nonoxygenated blood can not flow from right atrium to right ventricle due to nondevelopment or total agenesia of the tricuspid valve. The right ventricle is small and the pulmonary artery in some cases is hypoplastic. Atrial septal defect (ASD) or patent foramen oval (PFO) is necessary for passing the blood from the right atrium to the left system and without them the infants will not survive. The majority of infants die without palliative surgery. Tricuspid atresia was first discovered by Friedrich Ludwig kreysig in 1817, a German physician who found the obstruction between the right atrium and right ventricle in the autopsy of cyanotic infants.The classic term of tricuspid atresia was used firstly by schuberg in 1861. Tricuspid atresia occurs during prenatal development. In tricuspid atresia, there is no continuity between the right atrium and right ventricle. Inferior vena cava and superior vena cava collect venous nonoxygenated blood into the right atrium. Through atrial septal defect (ASD), blood come into the left atrium, then left ventricle andaorta.This blood is a mixture of saturated and unsaturated O2. If there is a ventricular septal defect (VSD), this mixed blood in the left ventricle flows into the right ventricle, then via pulmonary artery reaches pulmonary bed and becomes oxygenated, then returns back into the left atrium via pulmonary veins. In diminished pulmonary blood flow whether the flow is dependent on patent ductus arteriosus (PDA), the mixed-blood in aorta flows from this passage intopulmonary artery and pulmonary bed. In the presence of normal positioning of great arteries, cyanosis is more prominent and is affected by the size of VSD. Transposition of the great arteries (TGA) and subaortic stenosis are other associated anomalies. Some Genes mutation in tricuspid valvopathy includes : missense mutation in RASA1 that regulates Ras/ERK cascade, a missense mutation in NFATC1 that downregulates the Ras/ERK pathway. Familial recurrence of tricuspid atresia is rare. Few cases of an autosomal recessive pattern of inheritance are reported.Patients with tricuspid atresia should be differentiated from other cardiac causes of cyanosis and lung olygemia include: Tetralogy of Fallot, Total anomalous pulmonary venous connection, Pulmonary atresia, Tricuspid stenosis.

Historical Perspective

Tricuspid atresia was first discovered by Friedrich Ludwig kreysig in 1817, a German physician who found the obstruction between the right atrium and right ventricle in the autopsy of cyanotic infants. The classic term of tricuspid atresia was used firstly by schuberg in 1861.

Classification

Pathophysiology

Tricuspid atresia occurs during prenatal development. In tricuspid atresia, there is no continuity between the right atrium and right ventricle. Inferior vena cava and superior vena cava collect venous nonoxygenated blood into the right atrium. Through atrial septal defect (ASD), blood come into the left atrium, then left ventricle andaorta.This blood is a mixture of saturated and unsaturated O2. If there is a ventricular septal defect (VSD), this mixed blood in the left ventricle flows into the right ventricle, then via pulmonary artery reaches pulmonary bed and becomes oxygenated, then returns back into the left atrium viapulmonary veins. In diminished pulmonary blood flow whether the flow is dependent on patent ductus arteriosus (PDA), the mixed-blood in aorta flows from this passage into pulmonary artery and pulmonary bed. In the presence of normal positioning of great arteries, cyanosis is more prominent and is affected by the size of VSD. Transpositioning great arteries (TGA) and subaortic stenosis are other associated anomalies.

Causes

Some Genes mutation in tricuspid valvopathy includes : missense mutation in RASA1 that regulates Ras/ERK cascade, a missense mutation in NFATC1 that downregulates the Ras/ERK pathway. Familial recurrence of tricuspid atresia is rare. Few cases of an autosomal recessive pattern of inheritance are reported.

Differentiating tricuspid atresia from Other Diseases

Patients with tricuspid atresia should be differentiated from other cardiac causes of cyanosis and lung olygemia include: Tetralogy of Fallot, Total anomalous pulmonary venous connection, Pulmonary atresia, Tricuspid stenosis.

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Template:WH Template:WS